Yiting Wang

Yiting Wang

Auto-generated profile, based on publicly available information

Yiting Wang

Department of Pathology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, P.R. China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
QHQingru Hu
Qingru Hu
YWYiting Wang
Yiting Wang
SYSu Yao
Su Yao
YMYun Mao
Yun Mao
LLLiu Liu
Liu Liu
ZLZaiyi Liu
Zaiyi Liu
Desmoplastic reaction (DR) is one of many tumor–host interactions and is associated with the overall survival (OS) of patients with colorectal cancer. However, the clinical significance of DR requires further study in large multicenter cohorts and its predictive value in adjuvant chemotherapy (ACT) response remains unclear. Here, a total of 2,225 patients with colorectal cancer from five independent institutions were divided into primary (N = 1,012 from two centers) and validation (N = 1,213 from three centers) cohorts. DR was classified as immature, middle, or mature depending on the presence of myxoid stroma and hyalinized collagen bundles at the invasive front of the primary tumor. OS among different subgroups were compared, and the correlations of DR type with tumor-infiltrating lymphocytes (TILs) within stroma, tumor stroma ratio (TSR), and Stroma AReactive Invasion Front Areas (SARIFA) were also analyzed. In the primary cohort, patients with mature DR had the highest 5-year survival rate. These findings were confirmed in validation cohort. In addition, for stage II colorectal cancer, patients classified as non-mature DR would benefit from ACT compared with surgery alone. Furthermore, immature and middle DR were more associated with high TSR, less distribution of TILs within stroma and positive SARIFA compared with mature. Taken together, these data suggest that DR is a robust-independent prognostic factor for patients with colorectal cancer. For patients with stage II colorectal cancer, non-mature DR could be a potential marker for recognizing high-risk patients who may benefit from ACT. Significance: DR has the potential to identify patients with high-risk colorectal cancer and predict the efficacy of adjuvant chemotherapy in patients with stage II colorectal cancer. Our findings support reporting DR types as additional pathologic parameters in clinical practice for more precise risk stratification.

15 June 2023
Verified
Other
Open access
PDF file
QHQingru Hu
Qingru Hu
YWYiting Wang
Yiting Wang
SYSu Yao
Su Yao
YMYun Mao
Yun Mao
LLLiu Liu
Liu Liu
ZLZaiyi Liu
Zaiyi Liu
Predictive significance of other MSI status on the ACT of stage II CRC

31 May 2023
Verified
Other
Open access
PDF file
QHQingru Hu
Qingru Hu
YWYiting Wang
Yiting Wang
SYSu Yao
Su Yao
YMYun Mao
Yun Mao
LLLiu Liu
Liu Liu
ZLZaiyi Liu
Zaiyi Liu
Patient clinicopathologic characteristics in ACT and surgery only groups

31 May 2023
Verified
Other
Open access
QHQingru Hu
Qingru Hu
YWYiting Wang
Yiting Wang
SYSu Yao
Su Yao
YMYun Mao
Yun Mao
LLLiu Liu
Liu Liu
ZLZaiyi Liu
Zaiyi Liu
Desmoplastic reaction (DR) is one of many tumor-host interactions and is associated with the overall survival (OS) of patients with colorectal cancer (CRC). However, the clinical significance of DR requires further study in large multicenter cohorts and its predictive value in adjuvant chemotherapy (ACT) response remains unclear. Here, a total of 2225 CRC patients from five independent institutions were divided into primary (N=1012 from two centers) and validation (N=1213 from three centers) cohorts. DR were classified as immature, middle, or mature depending on the presence of myxoid stroma and hyalinized collagen bundles at the invasive front of the primary tumor. OS among different subgroups were compared, and the correlation of DR type with tumor infiltrating lymphocytes (TILs) within stroma, tumor stroma ratio (TSR) and Stroma AReactive Invasion Front Areas (SARIFA) were also analyzed. In the primary cohort, patients with mature DR had the highest 5-year survival rate. These findings were confirmed in validation cohort. Additionally, for stage II CRC, patients classified as non-mature DR would benefit from ACT compared with surgery alone. Furthermore, immature and middle DR were more associated with high TSR, less distribution of TILs within stroma and positive SARIFA compared to mature. Taken together, these data suggest that DR is a robust independent prognostic factor for CRC patients. For stage II CRC patients, non-mature DR could be a potential marker for recognizing high-risk patients who may benefit from ACT.


15 June 2023
Verified
Other
Open access
PDF file
QHQingru Hu
Qingru Hu
YWYiting Wang
Yiting Wang
SYSu Yao
Su Yao
YMYun Mao
Yun Mao
LLLiu Liu
Liu Liu
ZLZaiyi Liu
Zaiyi Liu
Patient clinicopathologic characteristics in ACT and surgery only groups